Muro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MURO, and what generic and branded alternatives to MURO drugs are available?
MURO has five approved drugs.
Drugs and US Patents for Muro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Muro | PRELONE | prednisolone | SYRUP;ORAL | 089654-001 | Jan 17, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Muro | VOLMAX | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 019604-002 | Dec 23, 1992 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Muro | LIQUID PRED | prednisone | SYRUP;ORAL | 087611-002 | Sep 7, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Muro | PROMETA | metaproterenol sulfate | SYRUP;ORAL | 072023-001 | Sep 15, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Muro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Muro | VOLMAX | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 019604-002 | Dec 23, 1992 | 4,851,229 | ⤷ Try a Trial |
Muro | VOLMAX | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 019604-001 | Dec 23, 1992 | 4,751,071 | ⤷ Try a Trial |
Muro | VOLMAX | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 019604-002 | Dec 23, 1992 | 4,751,071 | ⤷ Try a Trial |
Muro | VOLMAX | albuterol sulfate | TABLET, EXTENDED RELEASE;ORAL | 019604-001 | Dec 23, 1992 | 4,851,229 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.